Successful Desensitization of a Patient with Rituximab Hypersensitivity
Joint Authors
Ataca, Pinar
Atilla, Erden
Kendir, Resat
Bavbek, Sevim
Ozcan, Muhit
Source
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-01-20
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Rituximab is a monoclonal antibody which targets CD20 in B cells that is used for the treatment of CD20 positive oncologic and hematologic malignancies.
Rituximab causes hypersensitivity reactions during infusions.
The delay of treatment or loss of a highly efficient drug can be prevented by rapid drug desensitization method in patients who are allergic to rituximab.
We report a low grade B cell non-Hodgkin lymphoma patient with rituximab hypersensitivity successfully treated with rapid drug desensitization.
In experienced centers, drug desensitization is a novel modality to break through in case of hypersensitivity that should be considered.
American Psychological Association (APA)
Ataca, Pinar& Atilla, Erden& Kendir, Resat& Bavbek, Sevim& Ozcan, Muhit. 2015. Successful Desensitization of a Patient with Rituximab Hypersensitivity. Case Reports in Immunology،Vol. 2015, no. 2015, pp.1-4.
https://search.emarefa.net/detail/BIM-1058676
Modern Language Association (MLA)
Ataca, Pinar…[et al.]. Successful Desensitization of a Patient with Rituximab Hypersensitivity. Case Reports in Immunology No. 2015 (2015), pp.1-4.
https://search.emarefa.net/detail/BIM-1058676
American Medical Association (AMA)
Ataca, Pinar& Atilla, Erden& Kendir, Resat& Bavbek, Sevim& Ozcan, Muhit. Successful Desensitization of a Patient with Rituximab Hypersensitivity. Case Reports in Immunology. 2015. Vol. 2015, no. 2015, pp.1-4.
https://search.emarefa.net/detail/BIM-1058676
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1058676
